Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sofia, Barbar"'
Autor:
Fabiana Tezza, Giulia Lorenzoni, Danila Azzolina, Sofia Barbar, Lucia Anna Carmela Leone, Dario Gregori
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 5, p 343 (2021)
The present work aims to identify the predictors of COVID-19 in-hospital mortality testing a set of Machine Learning Techniques (MLTs), comparing their ability to predict the outcome of interest. The model with the best performance will be used to id
Externí odkaz:
https://doaj.org/article/79e00f592c104b84ba9fe940914b3f7c
Autor:
Giulia Lorenzoni, Fabiana Tezza, Lucia Anna Carmela Leone, Sofia Barbar, Danila Azzolina, Dario Gregori
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 343, p 343 (2021)
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 343, p 343 (2021)
The present work aims to identify the predictors of COVID-19 in-hospital mortality testing a set of Machine Learning Techniques (MLTs), comparing their ability to predict the outcome of interest. The model with the best performance will be used to id
Autor:
Maria Rita Marchi, Francesca Cassutti, Antonio Madia, Davide Bonaldo, Paola Giuriato, Guido Di Gregorio, Luca Cancian, Emanuela Zilli, Eleonora Bertoli, Sofia Barbar, Claudio Bozzoli
Publikováno v:
Bioengineering and Biomedical Signal and Image Processing ISBN: 9783030881627
BIOMESIP
BIOMESIP
The Covid-19 emergency has determined an unpredictable increase in the number of patients with Covid-like symptoms in the Emergency Department (ED) of Italian hospitals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79d79c98d1117276bb977ac95be95220
https://doi.org/10.1007/978-3-030-88163-4_41
https://doi.org/10.1007/978-3-030-88163-4_41
Autor:
Sofia Barbar, Helia Robert-Ebadi, Paolo Prandoni, Frédéric Glauser, Mathieu Nendaz, Marc Blondon, Marc Philip Righini
Publikováno v:
Journal of Thrombosis and Haemostasis, Vol. 18, No 3 (2020) pp. 676-680
BACKGROUND The simplified Geneva risk assessment model (RAM) predicts the risk of hospitalization-related venous thromboembolism (VTE) in medical inpatients in its developmental cohort but has not been validated. OBJECTIVES To externally validate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c7dda40171ac6d60c2c2ad813de63fd
http://hdl.handle.net/11577/3344376
http://hdl.handle.net/11577/3344376
Autor:
Adriana Visonà, Martin H. Prins, Paolo Prandoni, Nicola Mumoli, Maurizio Ciammaichella, Carlo Bova, Sofia Barbar, Eugenio Bucherini, Stefano Campostrini, Marica Perlati, Anthonie W. A. Lensing, Davide Imberti
Publikováno v:
New England Journal of Medicine, 375(16), 1524-1531. MASSACHUSETTS MEDICAL SOCIETY
BACKGROUND The prevalence of pulmonary embolism among patients hospitalized for syncope is not well documented, and current guidelines pay little attention to a diagnostic workup for pulmonary embolism in these patients. METHODS We performed a system
Publikováno v:
Journal of the American College of Cardiology, 74(23), 2950-2951. Elsevier Science
On the basis of the low observed prevalence of pulmonary embolism (PE) in a cohort of patients with syncope (BASEL IX [Basel Syncope Evaluation]; [NCT01548352][1]), Badertscher et al. ([1][2]) conclude that a systematic search for PE is not indicated
Autor:
Loris Roncon, Enrico Bernardi, Alice Spinazzè, Deisy Barrios, Francesco Dentali, Fulvio Morello, Gabriele Viviani, Claudio Poggioni, Iolanda Enea, Sara Giatti, E. Bucherini, Fabrizio Bottino, Peiman Nazerian, Andrés Quezada, M. Vastola, Simone Vanni, L. Sardo, Sofia Barbar, Francesco Crocco, S. Barbar, G. De Morelli, A. Dall' Arche, S. Brescianini, F. Morello, Claudio Picariello, Nicola Mumoli, Raffaele Pesavento, Paolo Prandoni, Eugenio Bucherini, F. Stea, David Jiménez, Massimo Puato, I. Enea, Carlo Bova
The Bova score has shown usefulness in the identification of intermediate-high risk patients with acute pulmonary embolism (PE), but lacks prospective validation. The aim of this study was to prospectively validate the Bova score in different setting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44006dfce4135f2da3c8737728bc6647
http://hdl.handle.net/11383/2078015
http://hdl.handle.net/11383/2078015
Autor:
Paolo Prandoni, Sofia Barbar
Publikováno v:
Seminars in thrombosis and hemostasis. 43(5)
Deep vein thrombosis and pulmonary embolism are associated with considerable morbidity and mortality in hospitalized patients, accounting for up to 10% of hospitalization-related deaths in both surgical and medical patients. Pharmacologic thromboprop
Publikováno v:
Internal and Emergency Medicine. 9:617-622
The introduction of factor Xa inhibitors advocated the initiation of clinical trials that addressed the value of anticoagulation in patients with hemodynamically stable primary pulmonary embolism (PE). In the Matisse trial in patients with PE, fondap
Publikováno v:
European Journal of Internal Medicine. 25:25-30
The risk of recurrent thromboembolic disorders in the 10-year period following an episode of unprovoked venous thromboembolism (VTE) ranges between 30 and 50%, the rate being higher in patients with primary deep venous thrombosis (DVT) than in those